Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cells

Nephrology Dialysis Transplantation

Volumn 22, Issue 4, 2007, Pages 1078-1086

  Shiizaki, Kazuhiro ^a   Hayakawa, Naohiko ^b   Imazeki, Ikuo ^b   Hatamura, Ikuji ^a   Okada, Tadashi ^a   Negi, Shigeo ^a   Sakaguchi, Toshifumi ^a   Shigematsu, Takashi ^a   Akizawa, Tadao ^c  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

22 oxacalcitriol; 5 6 nephrectomy; Parathyroid gland; Renal osteodistrophy; Secondary hyperparathyroidism; Vitamin D receptor

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; VITAMIN D; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; CALCIUM INTAKE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TISSUE LEVEL; HORMONE INHIBITION; ISOTOPE LABELING; MALE; NEPHRECTOMY; NONHUMAN; PARATHYROID CELL; PARATHYROID GLAND; PHOSPHATE INTAKE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RADIOACTIVITY; RAT; SECONDARY HYPERPARATHYROIDISM;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCITRIOL; CALCIUM; DISEASE MODELS, ANIMAL; HYPERPARATHYROIDISM, SECONDARY; INJECTIONS; MALE; PARATHYROID GLANDS; PARATHYROID HORMONE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; UREMIA; VITAMIN D;

EID: 34047191422     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl713     Document Type: Article

References (20)

1. Fukuda N, Tanaka H, Tominaga Y et al. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1443
2. Gogusev J, Duchambon P, Hory B et al. Decreased expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 1997; 51: 328-336
3. London GM, Marty C, Marchais SJ et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15: 1943-1951
4. Kitaoka M, Fukagawa M, Ogata E, Kurokawa K. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kidney Int 1994; 46: 1110-1117
5. Naveh-Many T, Rahamimo R, Livin N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats: The effects of calcium, phosphate, and vitamin D. J Clin Invest 1995; 96: 1786-1793
6. Akizawa T, Ohashi Y, Akiba T et al. Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism. Ther Apher Dial 2004; 8: 480-491
7. Kitaoka M, Fukagawa M, Fukuda N et al. Direct calcitriol injections into enlarged parathyroid glands in chronic dialysis patients with severe parathyroid hyperfunction. Nephrol 1995; 1: 563-567
8. Shiizaki K, Hatamura I, Negi S et al. Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia. Kidney Int 2003; 64: 992-1003
9. Shiizaki K, Negi S, Mizobuchi M et al. Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant 2003; 18 [Suppl 3]: Iii42-iii46
10. Shiizaki K, Negi S, Hatamura I et al. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats. J Am Soc Nephrol 2005; 16: 97-108
11. Shiizaki K, Hatamura I, Negi S et al. Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism. Kidney Int 2006; 70: 486-495
12. 3H] 1,25-dihydroxyvitamin D3, determined by micro-autoradiography. Nephrol Dial Transplant 2002; 17 [Suppl 10]: 53-57
13. Stumpf WE. Techniques for the autoradiography of diffusible compounds. Method Cell Biol 1976; 13: 171-193
14. 3, Binding of highly concentrated OCT to VDR of PTC 1085 in human serum by liquid chromatography-mass spectrometry. J Chromatogr B 1998; 706: 261-267
15. 3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 1995; 136: 1419-1425
16. Bartolomé G, Sagrario C, Antonio C et al. Regulation of parathyroid vitamin D receptor expression by extracellular calcium. J Am Soc Nephrol 2002; 13: 2945-2952
17. Nykjaer A, Dragun D, Walther D et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999; 96: 507-515
18. Seqersten U, Correa P, Hewison M et al. 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 2002; 87: 2967-2972
19. Panda DK, Miao D, Bolivar I et al. Inactivation of 25-hydroxyvitamin D 1α-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004; 279: 16754-16766
20. Valrance ME, Welsh J. Breast cancer cell regulation by high-dose vitamin D compounds in the absence of nuclear vitamin D receptor. J Steroid Biochem Mol Biol 2004; 89-90: 221-225